Now approved for a new use
KADCYLA can now be used after surgery for people with HER2+ early
- who received treatment
before surgery that included a taxane and trastuzumab
- who had surgery and their cancer remained in the
tissue that was removed
HER2+: HER2 stands for human epidermal growth factor receptor 2.
If you need help paying for KADCYLA, there may be options to
Understand how KADCYLA is given for early breast cancer.
Starting the conversation
Questions to ask your doctor before and during treatment with KADCYLA.